Patent ID: 11865104
Assignee: THE CLEVELAND CLINIC FOUNDATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating cancer in a subject in need thereof by administering a therapeutically effective amount of a compound of Formula I:, wherein R1 and R2 are independently selected from CH3, CH2CH3, and C1-C6 alkyl, R3 is H and R4 is —CH3, or R3 and R4 are combined to form ═CH2 or a cyclopropyl group; and R5 and R6 are independently selected from H, halogen, —OH, —CF3, and C1-C6 alkyl, or R5 and R6 are combined to form ═O;
or a pharmaceutically acceptable salt thereof selected from the group of salts consisting of chloride, bromide, nitrate, ammonium, sulfate, tosylate, phosphate, tartrate, ethylenediamine, and maleate salts.